期刊文献+

PDCA循环法在精神心理科辅助用药奥拉西坦管理中的应用成效分析 被引量:4

Effect of PDCA cycle on the clinical use of adjuvant drug oxiracetam injection in psychiatric department
下载PDF
导出
摘要 目的探讨PDCA循环法在辅助用药奥拉西坦管理中的应用效果,为其临床应用指导原则的建立提供参考。方法采用PDCA循环管理方法,对中山大学附属第三医院精神心理科奥拉西坦用药现状进行调查,总结并归纳目前应用存在的主要问题,经过分析制定奥拉西坦的管理措施,对其临床应用进行干预。通过比较干预前后奥拉西坦的不合理用药情况评价其干预效果。结果运用PDCA循环管理方法对奥拉西坦进行干预后,药物不合理应用的总体比例明显下降(56.76%vs8.33%,P<0.05)。结论PDCA循环管理方法可以有效促进医院辅助用药的合理化及规范化。 Objective The effect of PDCA cycle on the clinical use of oxiracetam injection in psychiatric department was explored to provide reference for the establishment of the corresponding guiding principles of clinical use.Methods The PDCA cycle method was used to investigate the oxiracetam injection usage in psychiatric department,set up related management measures after analysis and intervene the clinical use.The irrational rate of the use of oxiracetam injection before and after PDCA cycle was compared to evaluate the intervention effects. Results After continuous interventions,the irrational rate of the use of oxiracetam injection in psychiatric department decreased significantly from 56.76% to 8.33%( P <0.05).Conclusion PDCA cycle could effectively promote the rationalization and standardization of adjuvant drugs usage in hospital.
作者 李烨 全恩希 LI Ye;QUAN En-xi(The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,510630,China)
出处 《延安大学学报(医学科学版)》 2019年第3期72-75,共4页 Journal of Yan'an University:Medical Science Edition
关键词 奥拉西坦 辅助用药 处方点评 PDCA Oxiracetam Adjuvant drugs Prescription comment PDCA
  • 相关文献

参考文献17

二级参考文献142

  • 1吴家幂,刘春梅,李珺.脑出血后周边组织继发性脑损伤炎性机制的研究[J].临床神经病学杂志,2004,17(4):278-280. 被引量:87
  • 2黄玉青,秦扬.应用PDCA循环管理模式对医疗服务质量影响的分析[J].中国热带医学,2007,7(6):1060-1060. 被引量:6
  • 3胡晋红.实用医院药学[M].上海:上海科学技术出版社,2007:86-88.
  • 4Hall ED, Von Voigtlander PF. Facilitatoty effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission[J]. Neuropharmacology,1987, 26:1573- 1579.
  • 5Consolo S, Salmoiraghi P, Amoroso D, et al. Treatment with oxiracetam or choline restores cholinergic biochemical and pharmacological activities in striata of decorticated rats[J]. J Neurochem, 1990, 54(2) :571-577.
  • 6Ammassari-Teule M, Castellano C, Sansone M. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptie muscarinic antagonist secoverine in mice[J].Behav Brain Res, 1992, 47:93--95.
  • 7Sansone M, Castellano C, Battaglia M, et al. Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice[J]. Pharmacol Biochem Behav,1991, 39 : 197--200.
  • 8Mochizuki D, Sugiyama S, Shinoda Y. Biochemical studies of oxiracetam (CT-848) on cholinergic neutons [J]. Nippon Yakurigaku Zasshi, 1992, 99(1) : 27-35.
  • 9Sansone M, Castellano C, Palazzesi S, et al. Effects of oxiracetam, physostigmine, and their combination on active and passive avoidance learning in mice[J]. Pharmacol Biochem Behav, 1993, 44 ( 2 ) : 451-455.
  • 10Hlinak Z, Krejci I. Oxiracetam prevents the MK- 801 induced amnesia for the elevated plus maze in mice[J]. Behav Brain Res, 2000, 117 (1/2): 147- 151.

共引文献241

同被引文献35

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部